Once in a while, a court decision provides not just guidance for participants in corporate transactions but also can serve as a wakeup call for the players' legal advisors.

The European Commission has presented new draft Guidelines on Pharmacovigilance for Medicinal Products for Human Use in the EU (Volume 9A). These revised Guidelines, if adopted, will be of great importance to how drug safety is conducted in the EU. Stakeholder comments are due by March 17, 2006.

The decision discussed provides insight into the potential treatment of future “data breach” cases where it is unclear whether the data in question has in fact been accessed by those who have unlawfully obtained the device on which the data is stored.

Recent efforts by the California Legislature to increase corporate boardroom diversity hit a road bump due to the Los Angeles County Superior Court decision earlier this month in Crest v. Padilla...

Over the past several months, a number of decisions released by the Delaware courts have begun to grapple with the new Zuckerberg three-part demand futility standard announced by the Delaware Supreme Court in September.

On August 15, 2017, the Ninth Circuit again addressed whether a violation of the FCRA constitutes a sufficiently concrete and particularized harm to satisfy Article III's injury-in-fact requirement.

Securities class actions against life sciences companies are almost always second-order problems. The first-order problem is a business or regulatory setback that, when disclosed by the company...

District court judge finds that FERC may not pursue joint and several liability and disgorgement in Coaltrain case.

The U.S. Environmental Protection Agency (EPA or Agency) has released its final human health toxicity assessments for a subgroup of PFAS chemicals known as GenX (i.e., hexafluoropropylene oxide dimer acid and its ammonium salt).

On August 15, the FTC announced that it had reached an agreement with Uber to settle allegations that the company had made deceptive claims about its privacy and data security practices.

On October 29, 2021, the Delaware Court of Chancery issued a rare opinion holding that plaintiffs had succeeded in pleading that a board of directors wrongfully had refused their demand to pursue certain claims.

On October 13, 2021, the DOL released a proposed rule that would amend the DOL's investment duties regulation with respect to the consideration of ESG factors in the selection of investments for retirement plans ...

This article summarizes the key implications of the first opinion of the Roberts Court to address the Religious Freedom Restorations Act (RFRA).

Recent final and proposed EPA rules regulating cooling water intakes promise to add a significant new hurdle for utilities and manufacturers using cooling water when they seek to renew their National Pollutant Discharge Elimination System permits.

When faced with allegations of securities fraud, a defendant's reliance on a robust and well-functioning disclosure process can be a powerful tool to negate scienter, i.e., fraudulent intent.

This post seeks to help parties navigate issues arising from COVID-19 risks from an employment and privacy law perspective in both the United States and Europe.

We previously wrote about the MultiPlan Corp. SPAC litigation relating to the de-SPAC merger of Churchill Capital Corp. III ("Churchill") and its target, MultiPlan Corp.

The Federal Communications Commission voted unanimously to amend its rules restricting transmission of unsolicited commercial facsimile messages to implement the Junk Fax Prevention Act of 2005.

One of the most effective—but underutilized—defenses against claim a of securities fraud is a disclosure process defense: that the defendants reasonably relied on a robust process for drafting...

The Delaware Supreme Court recently affirmed Vice Chancellor Laster's much talked of AB Stable post-trial decision, holding that the buyer of a $5.8 billion hotel portfolio could terminate...